Universal Vision Biotechnology Co., Ltd. (TPEX:3218)

TPEX:3218 Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	935.88	506.85	1,063	703.02	534.19	616
Short-Term Investments	92.98	115.22	578.36	576.62	505.81	461.75
Trading Asset Securities	1,338	1,295	-	-	-	-
Cash & Short-Term Investments	2,367	1,917	1,641	1,280	1,040	1,078
Cash Growth	21.01%	16.85%	28.23%	23.04%	-3.50%	51.56%
Accounts Receivable	522.21	565.57	584.25	581.82	534.93	377.13
Other Receivables	11.87	11.9	2.17	3.37	11.31	33.8
Receivables	534.07	577.47	586.42	585.18	546.25	410.92
Inventory	297.75	289.73	294.52	227.62	115.65	62.62
Other Current Assets	64.23	57.19	58.03	66.54	77.21	90.78
Total Current Assets	3,263	2,842	2,580	2,159	1,779	1,642
Property, Plant & Equipment	2,689	2,673	2,323	2,206	1,724	1,413
Long-Term Investments	115.32	111.07	-	-	-	-
Other Intangible Assets	24.33	22.79	22.98	25.91	26.57	26.52
Long-Term Deferred Tax Assets	69.07	72.26	67.25	55.91	48.31	34.47
Other Long-Term Assets	49.84	41.34	137.06	59.25	171.76	53.11
Total Assets	6,211	5,763	5,131	4,506	3,750	3,169
Accounts Payable	298.06	268.07	312.31	254.55	210.5	122.93
Accrued Expenses	195.73	226.34	226.54	210.26	170.08	128.1
Short-Term Debt	42.61	92.01	8.67	-	-	176.9
Current Portion of Long-Term Debt	-	-	1.3	9.17	9.03	-
Current Portion of Leases	178.19	178.4	155.27	141.45	130.72	108
Current Income Taxes Payable	232.07	154.45	162.57	134.37	85.7	77.44
Current Unearned Revenue	44.61	25.12	24.19	23.32	16.24	14.22
Other Current Liabilities	835.2	146.34	132.25	137.25	109.39	125.83
Total Current Liabilities	1,834	1,091	1,023	910.38	731.66	753.41
Long-Term Debt	-	-	-	1.32	10.33	-
Long-Term Leases	752.6	783.83	613.02	631.7	617.45	329.24
Long-Term Deferred Tax Liabilities	62.31	60.93	58.39	44.26	24.94	-
Other Long-Term Liabilities	63	71.49	93.12	88.8	36.78	47.04
Total Liabilities	2,711	2,007	1,788	1,676	1,421	1,130
Common Stock	847.25	847.25	847.25	799.29	761.23	761.23
Additional Paid-In Capital	381.92	381.92	381.92	381.92	381.92	381.92
Retained Earnings	2,116	2,388	1,960	1,488	1,056	779.86
Comprehensive Income & Other	11.58	4.51	-11.38	-5.04	-10.37	-9.12
Total Common Equity	3,356	3,622	3,178	2,664	2,188	1,914
Minority Interest	142.88	133.72	165.33	165.02	140.13	125.55
Shareholders' Equity	3,499	3,756	3,343	2,829	2,328	2,039
Total Liabilities & Equity	6,211	5,763	5,131	4,506	3,750	3,169
Total Debt	973.4	1,054	778.26	783.65	767.53	614.14
Net Cash (Debt)	1,393	863.2	862.65	495.99	272.47	463.61
Net Cash Growth	19.55%	0.07%	73.92%	82.03%	-41.23%	261.16%
Net Cash Per Share	16.40	10.16	10.16	5.85	3.21	5.46
Filing Date Shares Outstanding	84.73	84.73	84.73	84.72	84.72	84.72
Total Common Shares Outstanding	84.73	84.73	84.73	84.72	84.72	84.72
Working Capital	1,429	1,751	1,557	1,249	1,047	888.66
Book Value Per Share	39.61	42.75	37.51	31.45	25.83	22.59
Tangible Book Value	3,332	3,599	3,155	2,638	2,162	1,887
Tangible Book Value Per Share	39.33	42.48	37.23	31.14	25.52	22.28
Land	179.87	179.87	179.87	179.87	179.87	179.87
Buildings	67.11	67.11	67.11	66.76	66.76	66.65
Machinery	2,536	2,442	2,165	1,884	1,480	1,346
Construction In Progress	122.41	96.01	32.82	91.84	-	-
Leasehold Improvements	652.6	643.69	615.67	473.07	340.85	306.52

Source: S&P Global Market Intelligence. Standard template. Financial Sources.